Pathophysiological role of endothelial biomarkers in Bothrops sp. venom-induced renal dysfunction and the therapeutic effect of antivenom
- PMID: 40525140
- PMCID: PMC12167772
- DOI: 10.1016/j.toxcx.2025.100226
Pathophysiological role of endothelial biomarkers in Bothrops sp. venom-induced renal dysfunction and the therapeutic effect of antivenom
Abstract
Snakebite antivenom (SAV) is the standard treatment option to neutralize the toxic effects of snake venom, but their consequences on kidney function need to be better understood. This study aims to evaluate the effects of antivenom on kidney and endothelial biomarkers due to Bothrops venom in two subgroups of patients distinguished by the presence of hemorrhagic syndrome at admission. This prospective study included 34 snakebite patients admitted to a tertiary hospital in Northeast Brazil between August 2019 and November 2020, 50 % of whom experienced spontaneous bleeding. Endothelial and kidney damage biomarkers were analyzed at three time points: before antivenom infusion and after 10 h and 20 h of antivenom infusion. Bleeding patients exhibited higher urine Neutrophil Gelatinase-Associated Lipocalin (uNGAL) and Kidney Injury Molecule-1 (KIM-1) levels, indicating incomplete renal recovery until 20h after antivenom. This group showed higher serum angiopoietin-2 (Ang-2) levels and vascular cell adhesion molecule-1 (VCAM-1). VCAM-1 levels positively correlated with kidney biomarker levels at each time point, especially after SAV. uNGAL was variant across VCAM-1, Ang-1, and Ang-2 levels before antivenom. Elevated levels of uNGAL and KIM-1, observed 10 h after SAV administration, may indicate incomplete renal protection and a potential risk for the development of chronic kidney injury, requiring future follow-up.
Keywords: Angiopoietins; Antivenom; KIM-1; Kidney injury; Snakebite; Vascular cell adhesion molecule-1.
© 2025 The Authors.
Conflict of interest statement
The authors declare the following financial interests/personal relationships which may be considered as potential competing interests:Nicole Coelho Lopes reports financial support was provided by Foundation for Scientific and Technological Development and Support of Ceará. Ranieri Sales de Souza Santos reports financial support was provided by 10.13039/501100003593National Council for Scientific and Technological Development. Geraldo Bezerra da Silva reports a relationship with 10.13039/501100003593National Council for Scientific and Technological Development that includes: funding grants. Elizabeth De Francesco Daher reports a relationship with 10.13039/501100003593National Council for Scientific and Technological Development that includes: funding grants. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures





Similar articles
-
Acute Kidney Injury Induced by Bothrops Venom: Insights into the Pathogenic Mechanisms.Toxins (Basel). 2019 Mar 5;11(3):148. doi: 10.3390/toxins11030148. Toxins (Basel). 2019. PMID: 30841537 Free PMC article.
-
Bothrops snakebites in the Amazon: recovery from hemostatic disorders after Brazilian antivenom therapy.Clin Toxicol (Phila). 2020 Apr;58(4):266-274. doi: 10.1080/15563650.2019.1634273. Epub 2019 Jul 2. Clin Toxicol (Phila). 2020. PMID: 31264481
-
Role of endothelial biomarkers in predicting acute kidney injury in Bothrops envenoming.Toxicol Lett. 2021 Jul 1;345:61-66. doi: 10.1016/j.toxlet.2021.04.010. Epub 2021 Apr 16. Toxicol Lett. 2021. PMID: 33872748
-
Prospective review of cytotoxic snakebite envenomation in a paediatric population.Toxicon. 2021 Jan 30;190:73-78. doi: 10.1016/j.toxicon.2020.12.009. Epub 2020 Dec 17. Toxicon. 2021. PMID: 33340504 Review.
-
Snakebite envenoming in French Guiana: Assessment of the preclinical efficacy against the venom of Bothrops atrox of two polyspecific antivenoms.Toxicon. 2020 Jan 15;173:1-4. doi: 10.1016/j.toxicon.2019.11.001. Epub 2019 Nov 11. Toxicon. 2020. PMID: 31726079 Review.
References
-
- Albuquerque P.L.M.M., Paiva J.H.H.G.L., Martins A.M.C., Meneses G.C., Silva Júnior G.B. da, Buckley N., Daher E.D.F. Clinical assessment and pathophysiology of Bothrops venom-related acute kidney injury: a scoping review. J. Venom. Anim. Toxins Incl. Trop. Dis. 2020;26:1–17. doi: 10.1590/1678-9199-jvatitd-2019-0076. - DOI - PMC - PubMed
-
- Butantan I. 2022. Soro Antibotrópico (Pentavalente) - Bula Profissional; pp. 1–7.
-
- Cavalcante J.S., de Almeida D.E.G., Santos-Filho N.A., Sartim M.A., de Almeida Baldo A., Brasileiro L., Albuquerque P.L., Oliveira S.S., Sachett J.A.G., Monteiro W.M., Ferreira R.S. Crosstalk of inflammation and coagulation in Bothrops snakebite envenoming: Endogenous signaling pathways and pathophysiology. Int. J. Mol. Sci. 2023;24 doi: 10.3390/ijms241411508. - DOI - PMC - PubMed
-
- da Silva W.R.G.B., de Siqueira Santos L., Lira D., de Oliveira Luna K.P., Fook S.M.L., Alves R.R.N. Who are the most affected by Bothrops snakebite envenoming in Brazil? A Clinical-epidemiological profile study among the regions of the country. PLoS Neglected Trop. Dis. 2023;17:1–24. doi: 10.1371/journal.pntd.0011708. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources
Miscellaneous